Orthofix Medical (NASDAQ: OFIX) — Perfil da empresa, notícias e dados financeiros
Orthofix Medical develops orthopedic and spine solutions to enhance patient outcomes globally.
Orthofix Medical
Orthofix Medical (NASDAQ:OFIX) is a global medical device company focused on designing, developing, and delivering innovative orthopedic and spine solutions to improve patients' lives. It operates through various segments, including BioStimulation, Extremity Fixation, Spine Fixation, and Biologics, offering a wide range of products and services that aid in the treatment of bone and joint conditions. Orthofix is dedicated to advancing orthopedic care by investing in new technologies, clinical research, and education to provide comprehensive solutions that meet the evolving needs of healthcare professionals and patients. Its strategic objectives encompass expanding its portfolio through innovation and acquisitions, penetrating new and existing markets, and leveraging its global infrastructure to enhance operational efficiencies and growth.
Resumo
Operações
Produtos e/ou serviços de Orthofix Medical
- Bone Growth Therapy devices offer noninvasive, pain-free treatment to enhance bone healing.
- Spinal Implants provide innovative solutions for spinal disorders, ensuring improved patient outcomes.
- Biologics includes a range of products aimed at enhancing bone growth and healing.
- Orthopedic Solutions cover devices and tools designed for extremity and orthopedic surgeries.
- Motion Preservation technology focuses on preserving the natural movement of the spine.
- Sports Medicine products support the treatment and recovery of sports-related injuries and conditions.
equipe executiva do Orthofix Medical
- Massimo CalafiorePresident, CEO & Director
- Julie B. AndrewsChief Financial Officer
- Aviva McPherronPresident of Global Operations & Quality
- J. Andres CedronChief Legal Officer & Corporate Secretary
- Patrick FisherPresident of Global Biologics & Limb Reconstruction
- Geoffrey C. GillespieChief Accounting Officer
- Julie D. DeweyChief Investor Relations & Communications Officer
- Jill MasonChief Compliance & Risk Officer
- Stephanie WalshChief Human Resources Officer
- Beau StandishChief Enabling Technologies Officer
Últimas notícias sobre a Orthofix Medical
Principais indicadores financeiros
Resultados divulgados pela Orthofix Medical, em USD.
- Cap. de mercado
- 392,5 mi
- Receita (TTM)
- 833,2 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.5
- Dividend yield
- —
- Margem de lucro
- -7.4%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 822,3 mi | -68,5 mi | -92,2 mi | |
| 799,5 mi | -84,6 mi | -126 mi | |
| 746,6 mi | -139,1 mi | -151,4 mi | |
| 460,7 mi | -13,3 mi | -19,7 mi |